Literature DB >> 20033984

Role of endogenous testosterone concentration in pediatric stroke.

Sandra Normann1, Gabrielle de Veber, Manfred Fobker, Claus Langer, Gili Kenet, Timothy J Bernard, Barbara Fiedler, Ronald Sträter, Neil A Goldenberg, Ulrike Nowak-Göttl.   

Abstract

Previous studies have indicated a male predominance in pediatric stroke. To elucidate this gender disparity, total testosterone concentration was measured in children with arterial ischemic stroke (AIS; n = 72), children with cerebral sinovenous thrombosis (CSVT; n = 52), and 109 healthy controls. Testosterone levels above the 90th percentile for age and gender were documented in 10 children with AIS (13.9%) and 10 with CSVT (19.2%), totaling 16.7% of patients with cerebral thromboembolism overall, as compared with only 2 of 109 controls (1.8%; p = 0.002). In multivariate analysis with adjustment for total cholesterol level, hematocrit, and pubertal status, elevated testosterone was independently associated with increased disease risk (odds ratio [95% confidence interval]: overall = 3.98 [1.38-11.45]; AIS = 3.88 [1.13-13.35]; CSVT = 5.50 [1.65-18.32]). Further adjusted analyses revealed that, for each 1nmol/l increase in testosterone in boys, the odds of cerebral thromboembolism were increased 1.3-fold.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033984     DOI: 10.1002/ana.21840

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  25 in total

Review 1.  Sexual dimorphism in ischemic stroke: lessons from the laboratory.

Authors:  Bharti Manwani; Louise D McCullough
Journal:  Womens Health (Lond)       Date:  2011-05

2.  Neonatal testosterone exposure protects adult male rats from stroke.

Authors:  Rebecca W Persky; Fudong Liu; Yan Xu; Gillian Weston; Stephanie Levy; Charles E Roselli; Louise D McCullough
Journal:  Neuroendocrinology       Date:  2012-12-06       Impact factor: 4.914

3.  Comparative study of posterior and anterior circulation stroke in childhood: Results from the International Pediatric Stroke Study.

Authors:  Barbara Goeggel Simonetti; Mubeen F Rafay; Melissa Chung; Warren D Lo; Lauren A Beslow; Lori L Billinghurst; Christine K Fox; Alberto Pagnamenta; Maja Steinlin; Mark T Mackay
Journal:  Neurology       Date:  2019-12-19       Impact factor: 9.910

Review 4.  Baby STEPS: a giant leap for cell therapy in neonatal brain injury.

Authors:  Cesar V Borlongan; Michael D Weiss
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

Review 5.  Microglia and Neonatal Brain Injury.

Authors:  Carina Mallard; Marie-Eve Tremblay; Zinaida S Vexler
Journal:  Neuroscience       Date:  2018-01-17       Impact factor: 3.590

6.  Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and contributes to sub-chronic injury in experimental neonatal focal stroke.

Authors:  Sophorn Chip; David Fernández-López; Fan Li; Joel Faustino; Nikita Derugin; Zinaida S Vexler
Journal:  Brain Behav Immun       Date:  2016-11-09       Impact factor: 7.217

Review 7.  Interactions between age, sex, and hormones in experimental ischemic stroke.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Neurochem Int       Date:  2012-10-13       Impact factor: 3.921

Review 8.  Recent advances in childhood arterial ischemic stroke.

Authors:  Christine K Fox; Heather J Fullerton
Journal:  Curr Atheroscler Rep       Date:  2010-07       Impact factor: 5.113

Review 9.  Therapy in pediatric stroke.

Authors:  B Simma; I Höliner; J Luetschg
Journal:  Eur J Pediatr       Date:  2012-11-06       Impact factor: 3.183

10.  ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY.

Authors:  Mibel M Pabon; Cesar V Borlongan
Journal:  Future Neurol       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.